Our partner is a late-stage clinical company who is committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Their diversified portfolio is designed to make a significant impact on rare peripheral amyloid and neurodegenerative diseases.

This critical hire led the biometrics group which oversaw statistics, statistical programming, and data management. They were responsible for advancing our partner’s product pipeline through all stages of development, BLA filing and life-cycle management via the biometrics function. They also built, led and mentored a team.